The Cost of Drugs for Rare Diseases Is Threatening the U.S. Health Care System
Unless the United States acts now, we will no longer be able afford FDA-approved treatments for rare disease. Hard decisions are already being made.
Continue Reading https://hbr.org
Join the Discussion